nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—Prednisone—hematologic cancer	0.153	0.506	CrCtD
Ciclesonide—Prednisolone—hematologic cancer	0.149	0.494	CrCtD
Ciclesonide—NR3C1—hematologic cancer	0.105	1	CbGaD
Ciclesonide—SERPINA6—Triamcinolone—hematologic cancer	0.0275	0.124	CbGbCtD
Ciclesonide—SERPINA6—Prednisolone—hematologic cancer	0.0233	0.105	CbGbCtD
Ciclesonide—CES1—Irinotecan—hematologic cancer	0.0231	0.104	CbGbCtD
Ciclesonide—NR3C1—Triamcinolone—hematologic cancer	0.0129	0.0581	CbGbCtD
Ciclesonide—NR3C1—Betamethasone—hematologic cancer	0.011	0.0498	CbGbCtD
Ciclesonide—NR3C1—Prednisolone—hematologic cancer	0.0109	0.0492	CbGbCtD
Ciclesonide—NR3C1—Prednisone—hematologic cancer	0.0103	0.0464	CbGbCtD
Ciclesonide—CYP2D6—Lomustine—hematologic cancer	0.00709	0.032	CbGbCtD
Ciclesonide—NR3C1—Dexamethasone—hematologic cancer	0.00642	0.029	CbGbCtD
Ciclesonide—CYP2D6—Idarubicin—hematologic cancer	0.00632	0.0285	CbGbCtD
Ciclesonide—CYP2D6—Hydroxyurea—hematologic cancer	0.00537	0.0243	CbGbCtD
Ciclesonide—CYP3A4—Bexarotene—hematologic cancer	0.00485	0.0219	CbGbCtD
Ciclesonide—CYP2D6—Bortezomib—hematologic cancer	0.00467	0.0211	CbGbCtD
Ciclesonide—CYP3A4—Busulfan—hematologic cancer	0.00451	0.0204	CbGbCtD
Ciclesonide—CYP3A4—Lomustine—hematologic cancer	0.00451	0.0204	CbGbCtD
Ciclesonide—CYP3A4—Thiotepa—hematologic cancer	0.00402	0.0181	CbGbCtD
Ciclesonide—Flurandrenolide—Betamethasone—hematologic cancer	0.0038	0.0145	CrCrCtD
Ciclesonide—Flurandrenolide—Dexamethasone—hematologic cancer	0.0038	0.0145	CrCrCtD
Ciclesonide—Flurandrenolide—Prednisolone—hematologic cancer	0.00344	0.0131	CrCrCtD
Ciclesonide—CYP2D6—Imatinib—hematologic cancer	0.00342	0.0155	CbGbCtD
Ciclesonide—Testolactone—Dexamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Testolactone—Betamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Beclomethasone—Betamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Fluocinonide—Betamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Fluocinonide—Dexamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Prednicarbate—Betamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Beclomethasone—Dexamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Prednicarbate—Dexamethasone—hematologic cancer	0.00334	0.0127	CrCrCtD
Ciclesonide—Hydrocortamate—Prednisone—hematologic cancer	0.0033	0.0126	CrCrCtD
Ciclesonide—Fluocinonide—Triamcinolone—hematologic cancer	0.00326	0.0124	CrCrCtD
Ciclesonide—Prednicarbate—Triamcinolone—hematologic cancer	0.00326	0.0124	CrCrCtD
Ciclesonide—Testolactone—Triamcinolone—hematologic cancer	0.00326	0.0124	CrCrCtD
Ciclesonide—Beclomethasone—Triamcinolone—hematologic cancer	0.00326	0.0124	CrCrCtD
Ciclesonide—Fluocortolone—Dexamethasone—hematologic cancer	0.00325	0.0124	CrCrCtD
Ciclesonide—Fluocortolone—Betamethasone—hematologic cancer	0.00325	0.0124	CrCrCtD
Ciclesonide—Hydrocortamate—Prednisolone—hematologic cancer	0.00322	0.0123	CrCrCtD
Ciclesonide—Fluocortolone—Triamcinolone—hematologic cancer	0.00317	0.0121	CrCrCtD
Ciclesonide—Alclometasone—Betamethasone—hematologic cancer	0.00316	0.012	CrCrCtD
Ciclesonide—Alclometasone—Dexamethasone—hematologic cancer	0.00316	0.012	CrCrCtD
Ciclesonide—CYP3A4—Methoxsalen—hematologic cancer	0.00312	0.0141	CbGbCtD
Ciclesonide—CYP2D6—Nilotinib—hematologic cancer	0.00311	0.0141	CbGbCtD
Ciclesonide—Prednicarbate—Prednisone—hematologic cancer	0.0031	0.0118	CrCrCtD
Ciclesonide—Testolactone—Prednisone—hematologic cancer	0.0031	0.0118	CrCrCtD
Ciclesonide—CYP2D6—Vinorelbine—hematologic cancer	0.00309	0.0139	CbGbCtD
Ciclesonide—Alclometasone—Triamcinolone—hematologic cancer	0.00308	0.0118	CrCrCtD
Ciclesonide—Amcinonide—Dexamethasone—hematologic cancer	0.00307	0.0117	CrCrCtD
Ciclesonide—Amcinonide—Betamethasone—hematologic cancer	0.00307	0.0117	CrCrCtD
Ciclesonide—Budesonide—Betamethasone—hematologic cancer	0.00307	0.0117	CrCrCtD
Ciclesonide—Budesonide—Dexamethasone—hematologic cancer	0.00307	0.0117	CrCrCtD
Ciclesonide—Beclomethasone—Prednisolone—hematologic cancer	0.00302	0.0115	CrCrCtD
Ciclesonide—Prednicarbate—Prednisolone—hematologic cancer	0.00302	0.0115	CrCrCtD
Ciclesonide—Testolactone—Prednisolone—hematologic cancer	0.00302	0.0115	CrCrCtD
Ciclesonide—Fluocortolone—Prednisone—hematologic cancer	0.00301	0.0115	CrCrCtD
Ciclesonide—Amcinonide—Triamcinolone—hematologic cancer	0.003	0.0114	CrCrCtD
Ciclesonide—Budesonide—Triamcinolone—hematologic cancer	0.003	0.0114	CrCrCtD
Ciclesonide—Prednisone—Betamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—Flunisolide—Betamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—Flunisolide—Dexamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—Desonide—Dexamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—Desonide—Betamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—Clobetasol propionate—Betamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—Prednisone—Dexamethasone—hematologic cancer	0.00299	0.0114	CrCrCtD
Ciclesonide—CYP3A4—Bortezomib—hematologic cancer	0.00297	0.0134	CbGbCtD
Ciclesonide—Fluocortolone—Prednisolone—hematologic cancer	0.00294	0.0112	CrCrCtD
Ciclesonide—Alclometasone—Prednisone—hematologic cancer	0.00293	0.0112	CrCrCtD
Ciclesonide—Flunisolide—Triamcinolone—hematologic cancer	0.00292	0.0111	CrCrCtD
Ciclesonide—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00292	0.0111	CrCrCtD
Ciclesonide—Desonide—Triamcinolone—hematologic cancer	0.00292	0.0111	CrCrCtD
Ciclesonide—Prednisone—Triamcinolone—hematologic cancer	0.00292	0.0111	CrCrCtD
Ciclesonide—Paramethasone—Dexamethasone—hematologic cancer	0.00292	0.0111	CrCrCtD
Ciclesonide—Paramethasone—Betamethasone—hematologic cancer	0.00292	0.0111	CrCrCtD
Ciclesonide—Alclometasone—Prednisolone—hematologic cancer	0.00286	0.0109	CrCrCtD
Ciclesonide—Paramethasone—Triamcinolone—hematologic cancer	0.00285	0.0109	CrCrCtD
Ciclesonide—Amcinonide—Prednisone—hematologic cancer	0.00285	0.0109	CrCrCtD
Ciclesonide—Budesonide—Prednisone—hematologic cancer	0.00285	0.0109	CrCrCtD
Ciclesonide—CYP3A4—Daunorubicin—hematologic cancer	0.00284	0.0128	CbGbCtD
Ciclesonide—Amcinonide—Prednisolone—hematologic cancer	0.00278	0.0106	CrCrCtD
Ciclesonide—Budesonide—Prednisolone—hematologic cancer	0.00278	0.0106	CrCrCtD
Ciclesonide—Loteprednol—Dexamethasone—hematologic cancer	0.00278	0.0106	CrCrCtD
Ciclesonide—Loteprednol—Betamethasone—hematologic cancer	0.00278	0.0106	CrCrCtD
Ciclesonide—Clobetasol propionate—Prednisone—hematologic cancer	0.00277	0.0106	CrCrCtD
Ciclesonide—Flunisolide—Prednisone—hematologic cancer	0.00277	0.0106	CrCrCtD
Ciclesonide—Desonide—Prednisone—hematologic cancer	0.00277	0.0106	CrCrCtD
Ciclesonide—Rimexolone—Dexamethasone—hematologic cancer	0.00271	0.0104	CrCrCtD
Ciclesonide—Rimexolone—Betamethasone—hematologic cancer	0.00271	0.0104	CrCrCtD
Ciclesonide—Loteprednol—Triamcinolone—hematologic cancer	0.00271	0.0104	CrCrCtD
Ciclesonide—Flunisolide—Prednisolone—hematologic cancer	0.00271	0.0103	CrCrCtD
Ciclesonide—Prednisone—Prednisolone—hematologic cancer	0.00271	0.0103	CrCrCtD
Ciclesonide—Clobetasol propionate—Prednisolone—hematologic cancer	0.00271	0.0103	CrCrCtD
Ciclesonide—Desonide—Prednisolone—hematologic cancer	0.00271	0.0103	CrCrCtD
Ciclesonide—Paramethasone—Prednisone—hematologic cancer	0.0027	0.0103	CrCrCtD
Ciclesonide—Rimexolone—Triamcinolone—hematologic cancer	0.00265	0.0101	CrCrCtD
Ciclesonide—Paramethasone—Prednisolone—hematologic cancer	0.00264	0.0101	CrCrCtD
Ciclesonide—Methylprednisolone—Dexamethasone—hematologic cancer	0.0026	0.0099	CrCrCtD
Ciclesonide—Methylprednisolone—Betamethasone—hematologic cancer	0.0026	0.0099	CrCrCtD
Ciclesonide—Loteprednol—Prednisone—hematologic cancer	0.00258	0.00982	CrCrCtD
Ciclesonide—Prednisolone—Dexamethasone—hematologic cancer	0.00254	0.00969	CrCrCtD
Ciclesonide—Prednisolone—Betamethasone—hematologic cancer	0.00254	0.00969	CrCrCtD
Ciclesonide—Methylprednisolone—Triamcinolone—hematologic cancer	0.00254	0.00967	CrCrCtD
Ciclesonide—Rimexolone—Prednisone—hematologic cancer	0.00252	0.0096	CrCrCtD
Ciclesonide—Loteprednol—Prednisolone—hematologic cancer	0.00251	0.00959	CrCrCtD
Ciclesonide—CYP3A4—Cytarabine—hematologic cancer	0.00251	0.0113	CbGbCtD
Ciclesonide—Prednisolone—Triamcinolone—hematologic cancer	0.00248	0.00947	CrCrCtD
Ciclesonide—CYP3A4—Teniposide—hematologic cancer	0.00247	0.0112	CbGbCtD
Ciclesonide—Rimexolone—Prednisolone—hematologic cancer	0.00246	0.00937	CrCrCtD
Ciclesonide—Hydrocortisone—Betamethasone—hematologic cancer	0.00244	0.0093	CrCrCtD
Ciclesonide—Hydrocortisone—Dexamethasone—hematologic cancer	0.00244	0.0093	CrCrCtD
Ciclesonide—Methylprednisolone—Prednisone—hematologic cancer	0.00241	0.00918	CrCrCtD
Ciclesonide—Hydrocortisone—Triamcinolone—hematologic cancer	0.00238	0.00909	CrCrCtD
Ciclesonide—Prednisolone—Prednisone—hematologic cancer	0.00236	0.00899	CrCrCtD
Ciclesonide—Methylprednisolone—Prednisolone—hematologic cancer	0.00235	0.00896	CrCrCtD
Ciclesonide—CYP3A4—Ifosfamide—hematologic cancer	0.00228	0.0103	CbGbCtD
Ciclesonide—Hydrocortisone—Prednisone—hematologic cancer	0.00226	0.00863	CrCrCtD
Ciclesonide—Hydrocortisone—Prednisolone—hematologic cancer	0.00221	0.00842	CrCrCtD
Ciclesonide—CYP3A4—Imatinib—hematologic cancer	0.00218	0.00983	CbGbCtD
Ciclesonide—CYP3A4—Ruxolitinib—hematologic cancer	0.00205	0.00926	CbGbCtD
Ciclesonide—CYP3A4—Nilotinib—hematologic cancer	0.00198	0.00894	CbGbCtD
Ciclesonide—CYP3A4—Vinorelbine—hematologic cancer	0.00196	0.00886	CbGbCtD
Ciclesonide—CYP2D6—Vinblastine—hematologic cancer	0.0019	0.00859	CbGbCtD
Ciclesonide—CYP3A4—Triamcinolone—hematologic cancer	0.00179	0.00811	CbGbCtD
Ciclesonide—CYP3A4—Dasatinib—hematologic cancer	0.00175	0.0079	CbGbCtD
Ciclesonide—CYP3A4—Mitoxantrone—hematologic cancer	0.00173	0.0078	CbGbCtD
Ciclesonide—CYP3A4—Betamethasone—hematologic cancer	0.00154	0.00695	CbGbCtD
Ciclesonide—CYP3A4—Prednisolone—hematologic cancer	0.00152	0.00686	CbGbCtD
Ciclesonide—CYP3A4—Prednisone—hematologic cancer	0.00143	0.00648	CbGbCtD
Ciclesonide—CYP2D6—Dexamethasone—hematologic cancer	0.00141	0.00636	CbGbCtD
Ciclesonide—CYP3A4—Irinotecan—hematologic cancer	0.00136	0.00614	CbGbCtD
Ciclesonide—CYP3A4—Vinblastine—hematologic cancer	0.00121	0.00546	CbGbCtD
Ciclesonide—CYP3A4—Vincristine—hematologic cancer	0.00119	0.00537	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—hematologic cancer	0.00117	0.00528	CbGbCtD
Ciclesonide—CYP3A4—Etoposide—hematologic cancer	0.00109	0.00492	CbGbCtD
Ciclesonide—CYP3A4—Dexamethasone—hematologic cancer	0.000895	0.00405	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—hematologic cancer	0.000743	0.00336	CbGbCtD
Ciclesonide—CES1—hematopoietic system—hematologic cancer	0.000636	0.107	CbGeAlD
Ciclesonide—SERPINA6—hematopoietic system—hematologic cancer	0.000635	0.107	CbGeAlD
Ciclesonide—CES1—blood—hematologic cancer	0.000421	0.0709	CbGeAlD
Ciclesonide—SERPINA6—blood—hematologic cancer	0.000421	0.0708	CbGeAlD
Ciclesonide—SERPINA6—bone marrow—hematologic cancer	0.000407	0.0685	CbGeAlD
Ciclesonide—CES1—lung—hematologic cancer	0.000369	0.0621	CbGeAlD
Ciclesonide—SERPINA6—lung—hematologic cancer	0.000369	0.0621	CbGeAlD
Ciclesonide—CES1—testis—hematologic cancer	0.000348	0.0586	CbGeAlD
Ciclesonide—NR3C1—hematopoietic system—hematologic cancer	0.000278	0.0468	CbGeAlD
Ciclesonide—CES1—lymph node—hematologic cancer	0.000252	0.0425	CbGeAlD
Ciclesonide—NR3C1—gonad—hematologic cancer	0.000211	0.0356	CbGeAlD
Ciclesonide—CYP3A4—hematopoietic system—hematologic cancer	0.00021	0.0354	CbGeAlD
Ciclesonide—CYP2D6—hematopoietic system—hematologic cancer	0.000207	0.0348	CbGeAlD
Ciclesonide—NR3C1—blood—hematologic cancer	0.000184	0.031	CbGeAlD
Ciclesonide—NR3C1—bone marrow—hematologic cancer	0.000178	0.03	CbGeAlD
Ciclesonide—NR3C1—lung—hematologic cancer	0.000162	0.0272	CbGeAlD
Ciclesonide—NR3C1—testis—hematologic cancer	0.000152	0.0257	CbGeAlD
Ciclesonide—CYP3A4—blood—hematologic cancer	0.000139	0.0235	CbGeAlD
Ciclesonide—CYP2D6—blood—hematologic cancer	0.000137	0.0231	CbGeAlD
Ciclesonide—CYP2D6—testis—hematologic cancer	0.000113	0.0191	CbGeAlD
Ciclesonide—NR3C1—lymph node—hematologic cancer	0.00011	0.0186	CbGeAlD
Ciclesonide—Prednicarbate—NR3C1—hematologic cancer	0.000107	0.0745	CrCbGaD
Ciclesonide—Desonide—NR3C1—hematologic cancer	0.000101	0.0705	CrCbGaD
Ciclesonide—Loteprednol—NR3C1—hematologic cancer	9.77e-05	0.0679	CrCbGaD
Ciclesonide—Flurandrenolide—NR3C1—hematologic cancer	8.65e-05	0.0602	CrCbGaD
Ciclesonide—Hydrocortamate—NR3C1—hematologic cancer	8.37e-05	0.0582	CrCbGaD
Ciclesonide—Amcinonide—NR3C1—hematologic cancer	7.78e-05	0.0541	CrCbGaD
Ciclesonide—Budesonide—NR3C1—hematologic cancer	7.78e-05	0.0541	CrCbGaD
Ciclesonide—Rimexolone—NR3C1—hematologic cancer	7.32e-05	0.0509	CrCbGaD
Ciclesonide—Beclomethasone—NR3C1—hematologic cancer	6.9e-05	0.048	CrCbGaD
Ciclesonide—Fluocinonide—NR3C1—hematologic cancer	6.9e-05	0.048	CrCbGaD
Ciclesonide—Alclometasone—NR3C1—hematologic cancer	6.71e-05	0.0466	CrCbGaD
Ciclesonide—Flunisolide—NR3C1—hematologic cancer	6.53e-05	0.0454	CrCbGaD
Ciclesonide—Clobetasol propionate—NR3C1—hematologic cancer	6.53e-05	0.0454	CrCbGaD
Ciclesonide—Paramethasone—NR3C1—hematologic cancer	6.45e-05	0.0448	CrCbGaD
Ciclesonide—Methylprednisolone—NR3C1—hematologic cancer	6.08e-05	0.0423	CrCbGaD
Ciclesonide—Prednisone—NR3C1—hematologic cancer	4.65e-05	0.0323	CrCbGaD
Ciclesonide—Prednisolone—NR3C1—hematologic cancer	4.29e-05	0.0298	CrCbGaD
Ciclesonide—Hydrocortisone—ABCG2—hematologic cancer	3.8e-05	0.0264	CrCbGaD
Ciclesonide—Hydrocortisone—NR3C1—hematologic cancer	3.28e-05	0.0228	CrCbGaD
Ciclesonide—Methylprednisolone—ABCB1—hematologic cancer	2.94e-05	0.0204	CrCbGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	2.52e-05	0.00103	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	2.5e-05	0.00102	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	2.5e-05	0.00102	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	2.48e-05	0.00101	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	2.47e-05	0.00101	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	2.43e-05	0.000991	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—NCOR1—hematologic cancer	2.42e-05	0.000986	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	2.41e-05	0.000983	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	2.41e-05	0.000982	CbGpPWpGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	2.4e-05	0.000976	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	2.39e-05	0.000976	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	2.39e-05	0.000975	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	2.39e-05	0.000972	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.36e-05	0.000961	CbGpPWpGaD
Ciclesonide—Prednisone—ALB—hematologic cancer	2.35e-05	0.0164	CrCbGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.34e-05	0.000952	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.33e-05	0.000948	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	2.26e-05	0.000922	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	2.26e-05	0.000922	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—EP300—hematologic cancer	2.26e-05	0.00092	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—TGFB1—hematologic cancer	2.26e-05	0.000919	CbGpPWpGaD
Ciclesonide—Prednisone—ABCB1—hematologic cancer	2.25e-05	0.0156	CrCbGaD
Ciclesonide—Dyspnoea—Cisplatin—hematologic cancer	2.2e-05	0.000287	CcSEcCtD
Ciclesonide—Cough—Triamcinolone—hematologic cancer	2.19e-05	0.000286	CcSEcCtD
Ciclesonide—Asthenia—Thalidomide—hematologic cancer	2.18e-05	0.000285	CcSEcCtD
Ciclesonide—Dizziness—Vinorelbine—hematologic cancer	2.18e-05	0.000284	CcSEcCtD
Ciclesonide—Nausea—Lenalidomide—hematologic cancer	2.18e-05	0.000284	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—FAS—hematologic cancer	2.17e-05	0.000884	CbGpPWpGaD
Ciclesonide—Hypertension—Triamcinolone—hematologic cancer	2.17e-05	0.000283	CcSEcCtD
Ciclesonide—Urticaria—Mitoxantrone—hematologic cancer	2.16e-05	0.000282	CcSEcCtD
Ciclesonide—Nausea—Hydroxyurea—hematologic cancer	2.15e-05	0.00028	CcSEcCtD
Ciclesonide—Bronchitis—Epirubicin—hematologic cancer	2.14e-05	0.000279	CcSEcCtD
Ciclesonide—Pneumonia—Methotrexate—hematologic cancer	2.13e-05	0.000278	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—hematologic cancer	2.13e-05	0.000278	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Cisplatin—hematologic cancer	2.13e-05	0.000278	CcSEcCtD
Ciclesonide—Rash—Bortezomib—hematologic cancer	2.13e-05	0.000278	CcSEcCtD
Ciclesonide—Dermatitis—Bortezomib—hematologic cancer	2.12e-05	0.000277	CcSEcCtD
Ciclesonide—Infestation—Methotrexate—hematologic cancer	2.12e-05	0.000277	CcSEcCtD
Ciclesonide—Infestation NOS—Methotrexate—hematologic cancer	2.12e-05	0.000277	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	2.12e-05	0.000864	CbGpPWpGaD
Ciclesonide—Headache—Bortezomib—hematologic cancer	2.11e-05	0.000276	CcSEcCtD
Ciclesonide—Rash—Bleomycin—hematologic cancer	2.11e-05	0.000275	CcSEcCtD
Ciclesonide—Dermatitis—Bleomycin—hematologic cancer	2.11e-05	0.000275	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	2.1e-05	0.000857	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	2.1e-05	0.000857	CbGpPWpGaD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	2.1e-05	0.000274	CcSEcCtD
Ciclesonide—Asthenia—Carmustine—hematologic cancer	2.1e-05	0.000274	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.09e-05	0.000852	CbGpPWpGaD
Ciclesonide—Dry mouth—Triamcinolone—hematologic cancer	2.09e-05	0.000273	CcSEcCtD
Ciclesonide—Angioedema—Dexamethasone—hematologic cancer	2.08e-05	0.000272	CcSEcCtD
Ciclesonide—Angioedema—Betamethasone—hematologic cancer	2.08e-05	0.000272	CcSEcCtD
Ciclesonide—Dizziness—Thiotepa—hematologic cancer	2.08e-05	0.000271	CcSEcCtD
Ciclesonide—Asthenia—Alitretinoin—hematologic cancer	2.08e-05	0.000271	CcSEcCtD
Ciclesonide—Rash—Vinorelbine—hematologic cancer	2.08e-05	0.000271	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.08e-05	0.000846	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CASC3—hematologic cancer	2.08e-05	0.000845	CbGpPWpGaD
Ciclesonide—Dermatitis—Vinorelbine—hematologic cancer	2.07e-05	0.000271	CcSEcCtD
Ciclesonide—Prednisolone—ABCB1—hematologic cancer	2.07e-05	0.0144	CrCbGaD
Ciclesonide—Upper respiratory tract infection—Epirubicin—hematologic cancer	2.07e-05	0.00027	CcSEcCtD
Ciclesonide—Headache—Vinorelbine—hematologic cancer	2.06e-05	0.000269	CcSEcCtD
Ciclesonide—Conjunctivitis—Methotrexate—hematologic cancer	2.06e-05	0.000269	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—hematologic cancer	2.06e-05	0.000269	CcSEcCtD
Ciclesonide—Immune system disorder—Prednisone—hematologic cancer	2.06e-05	0.000269	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.06e-05	0.000838	CbGpPWpGaD
Ciclesonide—Asthenia—Ifosfamide—hematologic cancer	2.05e-05	0.000268	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.05e-05	0.000834	CbGpPWpGaD
Ciclesonide—Infection—Triamcinolone—hematologic cancer	2.04e-05	0.000266	CcSEcCtD
Ciclesonide—Weight increased—Epirubicin—hematologic cancer	2.03e-05	0.000264	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.02e-05	0.000824	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.02e-05	0.000823	CbGpPWpGaD
Ciclesonide—Dyspnoea—Etoposide—hematologic cancer	2.01e-05	0.000263	CcSEcCtD
Ciclesonide—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	2.01e-05	0.00082	CbGpPWpGaD
Ciclesonide—Dizziness—Thalidomide—hematologic cancer	2.01e-05	0.000262	CcSEcCtD
Ciclesonide—Nausea—Bortezomib—hematologic cancer	2e-05	0.000261	CcSEcCtD
Ciclesonide—Epistaxis—Methotrexate—hematologic cancer	2e-05	0.000261	CcSEcCtD
Ciclesonide—Asthenia—Vincristine—hematologic cancer	2e-05	0.000261	CcSEcCtD
Ciclesonide—Pneumonia—Epirubicin—hematologic cancer	2e-05	0.000261	CcSEcCtD
Ciclesonide—Nausea—Bleomycin—hematologic cancer	1.99e-05	0.000259	CcSEcCtD
Ciclesonide—Infestation NOS—Epirubicin—hematologic cancer	1.99e-05	0.000259	CcSEcCtD
Ciclesonide—Infestation—Epirubicin—hematologic cancer	1.99e-05	0.000259	CcSEcCtD
Ciclesonide—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	1.98e-05	0.000809	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTO1—hematologic cancer	1.98e-05	0.000808	CbGpPWpGaD
Ciclesonide—Rash—Thiotepa—hematologic cancer	1.98e-05	0.000259	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—hematologic cancer	1.98e-05	0.000259	CcSEcCtD
Ciclesonide—Dermatitis—Thiotepa—hematologic cancer	1.98e-05	0.000259	CcSEcCtD
Ciclesonide—Headache—Thiotepa—hematologic cancer	1.97e-05	0.000257	CcSEcCtD
Ciclesonide—Hypertension—Dexamethasone—hematologic cancer	1.97e-05	0.000257	CcSEcCtD
Ciclesonide—Hypertension—Betamethasone—hematologic cancer	1.97e-05	0.000257	CcSEcCtD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTO1—hematologic cancer	1.96e-05	0.000797	CbGpPWpGaD
Ciclesonide—Nausea—Vinorelbine—hematologic cancer	1.96e-05	0.000255	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	1.95e-05	0.000796	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Etoposide—hematologic cancer	1.95e-05	0.000255	CcSEcCtD
Ciclesonide—Asthenia—Mitoxantrone—hematologic cancer	1.95e-05	0.000254	CcSEcCtD
Ciclesonide—Asthenia—Irinotecan—hematologic cancer	1.95e-05	0.000254	CcSEcCtD
Ciclesonide—Fatigue—Etoposide—hematologic cancer	1.95e-05	0.000254	CcSEcCtD
Ciclesonide—Dizziness—Carmustine—hematologic cancer	1.93e-05	0.000252	CcSEcCtD
Ciclesonide—Conjunctivitis—Epirubicin—hematologic cancer	1.93e-05	0.000252	CcSEcCtD
Ciclesonide—Urinary tract infection—Epirubicin—hematologic cancer	1.93e-05	0.000252	CcSEcCtD
Ciclesonide—Rash—Thalidomide—hematologic cancer	1.92e-05	0.00025	CcSEcCtD
Ciclesonide—Dermatitis—Thalidomide—hematologic cancer	1.92e-05	0.00025	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—hematologic cancer	1.91e-05	0.00025	CcSEcCtD
Ciclesonide—Haemoglobin—Methotrexate—hematologic cancer	1.91e-05	0.00025	CcSEcCtD
Ciclesonide—Dizziness—Alitretinoin—hematologic cancer	1.91e-05	0.00025	CcSEcCtD
Ciclesonide—Headache—Thalidomide—hematologic cancer	1.91e-05	0.000249	CcSEcCtD
Ciclesonide—Haemorrhage—Methotrexate—hematologic cancer	1.9e-05	0.000249	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	1.9e-05	0.000774	CbGpPWpGaD
Ciclesonide—Asthenia—Gemcitabine—hematologic cancer	1.9e-05	0.000248	CcSEcCtD
Ciclesonide—Dizziness—Ifosfamide—hematologic cancer	1.89e-05	0.000247	CcSEcCtD
Ciclesonide—Pharyngitis—Methotrexate—hematologic cancer	1.89e-05	0.000247	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—hematologic cancer	1.88e-05	0.000245	CcSEcCtD
Ciclesonide—Epistaxis—Epirubicin—hematologic cancer	1.87e-05	0.000244	CcSEcCtD
Ciclesonide—Nausea—Thiotepa—hematologic cancer	1.87e-05	0.000244	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	1.87e-05	0.000244	CcSEcCtD
Ciclesonide—CYP2D6—Biological oxidations—UGT1A1—hematologic cancer	1.86e-05	0.00076	CbGpPWpGaD
Ciclesonide—Sinusitis—Epirubicin—hematologic cancer	1.86e-05	0.000243	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	1.86e-05	0.000759	CbGpPWpGaD
Ciclesonide—Pneumonia—Doxorubicin—hematologic cancer	1.85e-05	0.000241	CcSEcCtD
Ciclesonide—Infection—Betamethasone—hematologic cancer	1.85e-05	0.000241	CcSEcCtD
Ciclesonide—Infection—Dexamethasone—hematologic cancer	1.85e-05	0.000241	CcSEcCtD
Ciclesonide—Dizziness—Vincristine—hematologic cancer	1.84e-05	0.000241	CcSEcCtD
Ciclesonide—Rash—Carmustine—hematologic cancer	1.84e-05	0.00024	CcSEcCtD
Ciclesonide—Dermatitis—Carmustine—hematologic cancer	1.84e-05	0.00024	CcSEcCtD
Ciclesonide—CYP2D6—Metapathway biotransformation—UGT1A1—hematologic cancer	1.84e-05	0.000749	CbGpPWpGaD
Ciclesonide—Infestation NOS—Doxorubicin—hematologic cancer	1.84e-05	0.00024	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—hematologic cancer	1.84e-05	0.00024	CcSEcCtD
Ciclesonide—Headache—Carmustine—hematologic cancer	1.83e-05	0.000239	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	1.83e-05	0.000745	CbGpPWpGaD
Ciclesonide—Dyspnoea—Triamcinolone—hematologic cancer	1.83e-05	0.000238	CcSEcCtD
Ciclesonide—Rash—Alitretinoin—hematologic cancer	1.82e-05	0.000238	CcSEcCtD
Ciclesonide—Dermatitis—Alitretinoin—hematologic cancer	1.82e-05	0.000238	CcSEcCtD
Ciclesonide—Headache—Alitretinoin—hematologic cancer	1.81e-05	0.000237	CcSEcCtD
Ciclesonide—Angioedema—Prednisone—hematologic cancer	1.81e-05	0.000237	CcSEcCtD
Ciclesonide—Nausea—Thalidomide—hematologic cancer	1.81e-05	0.000236	CcSEcCtD
Ciclesonide—Dyspepsia—Triamcinolone—hematologic cancer	1.8e-05	0.000235	CcSEcCtD
Ciclesonide—Rash—Ifosfamide—hematologic cancer	1.8e-05	0.000235	CcSEcCtD
Ciclesonide—Dermatitis—Ifosfamide—hematologic cancer	1.8e-05	0.000235	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	1.8e-05	0.000732	CbGpPWpGaD
Ciclesonide—Dizziness—Irinotecan—hematologic cancer	1.8e-05	0.000234	CcSEcCtD
Ciclesonide—Urticaria—Etoposide—hematologic cancer	1.79e-05	0.000234	CcSEcCtD
Ciclesonide—Haemoglobin—Epirubicin—hematologic cancer	1.79e-05	0.000234	CcSEcCtD
Ciclesonide—Rhinitis—Epirubicin—hematologic cancer	1.79e-05	0.000233	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—hematologic cancer	1.79e-05	0.000233	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—hematologic cancer	1.79e-05	0.000233	CcSEcCtD
Ciclesonide—Haemorrhage—Epirubicin—hematologic cancer	1.78e-05	0.000233	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	1.78e-05	0.000725	CbGpPWpGaD
Ciclesonide—Urticaria—Prednisolone—hematologic cancer	1.77e-05	0.000231	CcSEcCtD
Ciclesonide—Asthenia—Cisplatin—hematologic cancer	1.77e-05	0.000231	CcSEcCtD
Ciclesonide—Pharyngitis—Epirubicin—hematologic cancer	1.77e-05	0.000231	CcSEcCtD
Ciclesonide—Fatigue—Triamcinolone—hematologic cancer	1.77e-05	0.000231	CcSEcCtD
Ciclesonide—Rash—Vincristine—hematologic cancer	1.76e-05	0.000229	CcSEcCtD
Ciclesonide—Dermatitis—Vincristine—hematologic cancer	1.76e-05	0.000229	CcSEcCtD
Ciclesonide—Headache—Vincristine—hematologic cancer	1.75e-05	0.000228	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	1.74e-05	0.00071	CbGpPWpGaD
Ciclesonide—Nausea—Carmustine—hematologic cancer	1.74e-05	0.000226	CcSEcCtD
Ciclesonide—Epistaxis—Doxorubicin—hematologic cancer	1.73e-05	0.000226	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	1.72e-05	0.000703	CbGpPWpGaD
Ciclesonide—Sinusitis—Doxorubicin—hematologic cancer	1.72e-05	0.000225	CcSEcCtD
Ciclesonide—Immune system disorder—Methotrexate—hematologic cancer	1.72e-05	0.000224	CcSEcCtD
Ciclesonide—Nausea—Alitretinoin—hematologic cancer	1.72e-05	0.000224	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methotrexate—hematologic cancer	1.72e-05	0.000224	CcSEcCtD
Ciclesonide—Hypertension—Prednisone—hematologic cancer	1.71e-05	0.000224	CcSEcCtD
Ciclesonide—Rash—Irinotecan—hematologic cancer	1.71e-05	0.000223	CcSEcCtD
Ciclesonide—Rash—Mitoxantrone—hematologic cancer	1.71e-05	0.000223	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—CREB1—hematologic cancer	1.71e-05	0.000697	CbGpPWpGaD
Ciclesonide—Dermatitis—Mitoxantrone—hematologic cancer	1.71e-05	0.000223	CcSEcCtD
Ciclesonide—Dermatitis—Irinotecan—hematologic cancer	1.71e-05	0.000223	CcSEcCtD
Ciclesonide—Headache—Mitoxantrone—hematologic cancer	1.7e-05	0.000222	CcSEcCtD
Ciclesonide—Headache—Irinotecan—hematologic cancer	1.7e-05	0.000222	CcSEcCtD
Ciclesonide—Nausea—Ifosfamide—hematologic cancer	1.7e-05	0.000222	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.69e-05	0.000221	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.69e-05	0.000221	CcSEcCtD
Ciclesonide—Arthralgia—Prednisone—hematologic cancer	1.69e-05	0.00022	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	1.68e-05	0.000686	CbGpPWpGaD
Ciclesonide—Rash—Gemcitabine—hematologic cancer	1.67e-05	0.000218	CcSEcCtD
Ciclesonide—Dermatitis—Gemcitabine—hematologic cancer	1.67e-05	0.000217	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—RB1—hematologic cancer	1.66e-05	0.000676	CbGpPWpGaD
Ciclesonide—Haemoglobin—Doxorubicin—hematologic cancer	1.66e-05	0.000216	CcSEcCtD
Ciclesonide—Headache—Gemcitabine—hematologic cancer	1.66e-05	0.000216	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.66e-05	0.000675	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.66e-05	0.000675	CbGpPWpGaD
Ciclesonide—Nausea—Vincristine—hematologic cancer	1.66e-05	0.000216	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—hematologic cancer	1.65e-05	0.000216	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—hematologic cancer	1.65e-05	0.000215	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.64e-05	0.000669	CbGpPWpGaD
Ciclesonide—Pharyngitis—Doxorubicin—hematologic cancer	1.64e-05	0.000214	CcSEcCtD
Ciclesonide—Dyspepsia—Dexamethasone—hematologic cancer	1.64e-05	0.000214	CcSEcCtD
Ciclesonide—Dyspepsia—Betamethasone—hematologic cancer	1.64e-05	0.000214	CcSEcCtD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.63e-05	0.000665	CbGpPWpGaD
Ciclesonide—Urticaria—Triamcinolone—hematologic cancer	1.63e-05	0.000212	CcSEcCtD
Ciclesonide—Dysgeusia—Methotrexate—hematologic cancer	1.62e-05	0.000212	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.62e-05	0.000661	CbGpPWpGaD
Ciclesonide—Asthenia—Etoposide—hematologic cancer	1.62e-05	0.000212	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.62e-05	0.00066	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—MTR—hematologic cancer	1.62e-05	0.000659	CbGpPWpGaD
Ciclesonide—Nausea—Mitoxantrone—hematologic cancer	1.61e-05	0.000211	CcSEcCtD
Ciclesonide—Nausea—Irinotecan—hematologic cancer	1.61e-05	0.000211	CcSEcCtD
Ciclesonide—Immune system disorder—Epirubicin—hematologic cancer	1.61e-05	0.00021	CcSEcCtD
Ciclesonide—Infection—Prednisone—hematologic cancer	1.61e-05	0.00021	CcSEcCtD
Ciclesonide—Mediastinal disorder—Epirubicin—hematologic cancer	1.61e-05	0.00021	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.61e-05	0.000209	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.61e-05	0.000209	CcSEcCtD
Ciclesonide—Back pain—Methotrexate—hematologic cancer	1.6e-05	0.000209	CcSEcCtD
Ciclesonide—Fatigue—Betamethasone—hematologic cancer	1.6e-05	0.000209	CcSEcCtD
Ciclesonide—Fatigue—Dexamethasone—hematologic cancer	1.6e-05	0.000209	CcSEcCtD
Ciclesonide—Hydrocortisone—ABCB1—hematologic cancer	1.58e-05	0.011	CrCbGaD
Ciclesonide—Nausea—Gemcitabine—hematologic cancer	1.57e-05	0.000205	CcSEcCtD
Ciclesonide—Rash—Cisplatin—hematologic cancer	1.55e-05	0.000203	CcSEcCtD
Ciclesonide—Dermatitis—Cisplatin—hematologic cancer	1.55e-05	0.000203	CcSEcCtD
Ciclesonide—CYP2D6—Biological oxidations—GSTT1—hematologic cancer	1.54e-05	0.000627	CbGpPWpGaD
Ciclesonide—Dysgeusia—Epirubicin—hematologic cancer	1.52e-05	0.000198	CcSEcCtD
Ciclesonide—Back pain—Epirubicin—hematologic cancer	1.5e-05	0.000196	CcSEcCtD
Ciclesonide—Dizziness—Etoposide—hematologic cancer	1.49e-05	0.000195	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—hematologic cancer	1.49e-05	0.000194	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—hematologic cancer	1.49e-05	0.000194	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.48e-05	0.000602	CbGpPWpGaD
Ciclesonide—Urticaria—Dexamethasone—hematologic cancer	1.48e-05	0.000193	CcSEcCtD
Ciclesonide—Urticaria—Betamethasone—hematologic cancer	1.48e-05	0.000193	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.48e-05	0.000193	CcSEcCtD
Ciclesonide—Dizziness—Prednisolone—hematologic cancer	1.47e-05	0.000192	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.47e-05	0.000599	CbGpPWpGaD
Ciclesonide—Asthenia—Triamcinolone—hematologic cancer	1.47e-05	0.000192	CcSEcCtD
Ciclesonide—Nausea—Cisplatin—hematologic cancer	1.46e-05	0.000191	CcSEcCtD
Ciclesonide—Cough—Methotrexate—hematologic cancer	1.45e-05	0.000189	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.44e-05	0.000588	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.44e-05	0.000588	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.44e-05	0.000587	CbGpPWpGaD
Ciclesonide—Dyspepsia—Prednisone—hematologic cancer	1.43e-05	0.000186	CcSEcCtD
Ciclesonide—Rash—Etoposide—hematologic cancer	1.42e-05	0.000186	CcSEcCtD
Ciclesonide—Dermatitis—Etoposide—hematologic cancer	1.42e-05	0.000186	CcSEcCtD
Ciclesonide—Headache—Etoposide—hematologic cancer	1.42e-05	0.000185	CcSEcCtD
Ciclesonide—Arthralgia—Methotrexate—hematologic cancer	1.41e-05	0.000184	CcSEcCtD
Ciclesonide—Chest pain—Methotrexate—hematologic cancer	1.41e-05	0.000184	CcSEcCtD
Ciclesonide—Dysgeusia—Doxorubicin—hematologic cancer	1.41e-05	0.000183	CcSEcCtD
Ciclesonide—Rash—Prednisolone—hematologic cancer	1.4e-05	0.000183	CcSEcCtD
Ciclesonide—Dermatitis—Prednisolone—hematologic cancer	1.4e-05	0.000183	CcSEcCtD
Ciclesonide—Fatigue—Prednisone—hematologic cancer	1.4e-05	0.000182	CcSEcCtD
Ciclesonide—Headache—Prednisolone—hematologic cancer	1.4e-05	0.000182	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—hematologic cancer	1.39e-05	0.000181	CcSEcCtD
Ciclesonide—Palpitations—Epirubicin—hematologic cancer	1.37e-05	0.000179	CcSEcCtD
Ciclesonide—Dizziness—Triamcinolone—hematologic cancer	1.36e-05	0.000177	CcSEcCtD
Ciclesonide—Cough—Epirubicin—hematologic cancer	1.35e-05	0.000177	CcSEcCtD
Ciclesonide—Infection—Methotrexate—hematologic cancer	1.34e-05	0.000175	CcSEcCtD
Ciclesonide—Nausea—Etoposide—hematologic cancer	1.34e-05	0.000175	CcSEcCtD
Ciclesonide—Hypertension—Epirubicin—hematologic cancer	1.34e-05	0.000175	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—RARS—hematologic cancer	1.34e-05	0.000545	CbGpPWpGaD
Ciclesonide—Asthenia—Betamethasone—hematologic cancer	1.33e-05	0.000174	CcSEcCtD
Ciclesonide—Asthenia—Dexamethasone—hematologic cancer	1.33e-05	0.000174	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.33e-05	0.000543	CbGpPWpGaD
Ciclesonide—Nausea—Prednisolone—hematologic cancer	1.32e-05	0.000173	CcSEcCtD
Ciclesonide—Arthralgia—Epirubicin—hematologic cancer	1.32e-05	0.000172	CcSEcCtD
Ciclesonide—Chest pain—Epirubicin—hematologic cancer	1.32e-05	0.000172	CcSEcCtD
Ciclesonide—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	1.3e-05	0.000528	CbGpPWpGaD
Ciclesonide—Rash—Triamcinolone—hematologic cancer	1.29e-05	0.000169	CcSEcCtD
Ciclesonide—Dry mouth—Epirubicin—hematologic cancer	1.29e-05	0.000169	CcSEcCtD
Ciclesonide—Dermatitis—Triamcinolone—hematologic cancer	1.29e-05	0.000168	CcSEcCtD
Ciclesonide—Urticaria—Prednisone—hematologic cancer	1.29e-05	0.000168	CcSEcCtD
Ciclesonide—Headache—Triamcinolone—hematologic cancer	1.28e-05	0.000168	CcSEcCtD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	1.28e-05	0.000521	CbGpPWpGaD
Ciclesonide—Palpitations—Doxorubicin—hematologic cancer	1.27e-05	0.000166	CcSEcCtD
Ciclesonide—Infection—Epirubicin—hematologic cancer	1.26e-05	0.000164	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.26e-05	0.000512	CbGpPWpGaD
Ciclesonide—Cough—Doxorubicin—hematologic cancer	1.25e-05	0.000163	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—hematologic cancer	1.24e-05	0.000162	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.23e-05	0.000161	CcSEcCtD
Ciclesonide—Dizziness—Dexamethasone—hematologic cancer	1.23e-05	0.00016	CcSEcCtD
Ciclesonide—Dizziness—Betamethasone—hematologic cancer	1.23e-05	0.00016	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—hematologic cancer	1.22e-05	0.00016	CcSEcCtD
Ciclesonide—Arthralgia—Doxorubicin—hematologic cancer	1.22e-05	0.00016	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.22e-05	0.000497	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	1.22e-05	0.000497	CbGpPWpGaD
Ciclesonide—Nausea—Triamcinolone—hematologic cancer	1.22e-05	0.000159	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.21e-05	0.000493	CbGpPWpGaD
Ciclesonide—Dyspnoea—Methotrexate—hematologic cancer	1.21e-05	0.000157	CcSEcCtD
Ciclesonide—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.2e-05	0.00049	CbGpPWpGaD
Ciclesonide—Dry mouth—Doxorubicin—hematologic cancer	1.2e-05	0.000156	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.19e-05	0.000486	CbGpPWpGaD
Ciclesonide—Dyspepsia—Methotrexate—hematologic cancer	1.19e-05	0.000155	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.17e-05	0.000478	CbGpPWpGaD
Ciclesonide—Rash—Dexamethasone—hematologic cancer	1.17e-05	0.000153	CcSEcCtD
Ciclesonide—Rash—Betamethasone—hematologic cancer	1.17e-05	0.000153	CcSEcCtD
Ciclesonide—Dermatitis—Betamethasone—hematologic cancer	1.17e-05	0.000153	CcSEcCtD
Ciclesonide—Dermatitis—Dexamethasone—hematologic cancer	1.17e-05	0.000153	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.17e-05	0.000152	CcSEcCtD
Ciclesonide—Fatigue—Methotrexate—hematologic cancer	1.17e-05	0.000152	CcSEcCtD
Ciclesonide—Headache—Betamethasone—hematologic cancer	1.16e-05	0.000152	CcSEcCtD
Ciclesonide—Headache—Dexamethasone—hematologic cancer	1.16e-05	0.000152	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—hematologic cancer	1.16e-05	0.000152	CcSEcCtD
Ciclesonide—Asthenia—Prednisone—hematologic cancer	1.16e-05	0.000152	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.15e-05	0.000151	CcSEcCtD
Ciclesonide—Dyspnoea—Epirubicin—hematologic cancer	1.13e-05	0.000147	CcSEcCtD
Ciclesonide—Dyspepsia—Epirubicin—hematologic cancer	1.11e-05	0.000145	CcSEcCtD
Ciclesonide—Nausea—Dexamethasone—hematologic cancer	1.1e-05	0.000144	CcSEcCtD
Ciclesonide—Nausea—Betamethasone—hematologic cancer	1.1e-05	0.000144	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.1e-05	0.000447	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.09e-05	0.000446	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.09e-05	0.000143	CcSEcCtD
Ciclesonide—Fatigue—Epirubicin—hematologic cancer	1.09e-05	0.000142	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—RARA—hematologic cancer	1.09e-05	0.000444	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—TET2—hematologic cancer	1.09e-05	0.000444	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.08e-05	0.000438	CbGpPWpGaD
Ciclesonide—Urticaria—Methotrexate—hematologic cancer	1.07e-05	0.00014	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.07e-05	0.000438	CbGpPWpGaD
Ciclesonide—Dizziness—Prednisone—hematologic cancer	1.07e-05	0.00014	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.07e-05	0.000436	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.07e-05	0.000139	CcSEcCtD
Ciclesonide—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	1.07e-05	0.000434	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.06e-05	0.000434	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.06e-05	0.000433	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.06e-05	0.000431	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	1.05e-05	0.000428	CbGpPWpGaD
Ciclesonide—Dyspnoea—Doxorubicin—hematologic cancer	1.04e-05	0.000136	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—hematologic cancer	1.03e-05	0.000135	CcSEcCtD
Ciclesonide—Rash—Prednisone—hematologic cancer	1.02e-05	0.000133	CcSEcCtD
Ciclesonide—Dermatitis—Prednisone—hematologic cancer	1.02e-05	0.000133	CcSEcCtD
Ciclesonide—Headache—Prednisone—hematologic cancer	1.01e-05	0.000132	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.01e-05	0.000413	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.01e-05	0.000132	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.01e-05	0.000412	CbGpPWpGaD
Ciclesonide—Fatigue—Doxorubicin—hematologic cancer	1.01e-05	0.000132	CcSEcCtD
Ciclesonide—Urticaria—Epirubicin—hematologic cancer	1.01e-05	0.000131	CcSEcCtD
Ciclesonide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.01e-05	0.00041	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1e-05	0.000408	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	9.92e-06	0.000404	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—hematologic cancer	9.87e-06	0.000402	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	9.81e-06	0.0004	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	9.8e-06	0.000399	CbGpPWpGaD
Ciclesonide—Asthenia—Methotrexate—hematologic cancer	9.71e-06	0.000127	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—DNMT3A—hematologic cancer	9.67e-06	0.000394	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	9.66e-06	0.000394	CbGpPWpGaD
Ciclesonide—Nausea—Prednisone—hematologic cancer	9.62e-06	0.000126	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—ELL—hematologic cancer	9.53e-06	0.000388	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	9.32e-06	0.00038	CbGpPWpGaD
Ciclesonide—Urticaria—Doxorubicin—hematologic cancer	9.31e-06	0.000121	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	9.29e-06	0.000379	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—hematologic cancer	9.21e-06	0.000375	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOR2—hematologic cancer	9.15e-06	0.000373	CbGpPWpGaD
Ciclesonide—Asthenia—Epirubicin—hematologic cancer	9.09e-06	0.000119	CcSEcCtD
Ciclesonide—Dizziness—Methotrexate—hematologic cancer	8.95e-06	0.000117	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	8.84e-06	0.00036	CbGpPWpGaD
Ciclesonide—Rash—Methotrexate—hematologic cancer	8.53e-06	0.000111	CcSEcCtD
Ciclesonide—Dermatitis—Methotrexate—hematologic cancer	8.52e-06	0.000111	CcSEcCtD
Ciclesonide—Headache—Methotrexate—hematologic cancer	8.48e-06	0.000111	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—AGO2—hematologic cancer	8.43e-06	0.000344	CbGpPWpGaD
Ciclesonide—Asthenia—Doxorubicin—hematologic cancer	8.41e-06	0.00011	CcSEcCtD
Ciclesonide—Dizziness—Epirubicin—hematologic cancer	8.37e-06	0.000109	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—H3F3B—hematologic cancer	8.26e-06	0.000337	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT3B—hematologic cancer	8.26e-06	0.000337	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PHYH—hematologic cancer	8.17e-06	0.000333	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GMPS—hematologic cancer	8.17e-06	0.000333	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FTCD—hematologic cancer	8.17e-06	0.000333	CbGpPWpGaD
Ciclesonide—Nausea—Methotrexate—hematologic cancer	8.04e-06	0.000105	CcSEcCtD
Ciclesonide—Rash—Epirubicin—hematologic cancer	7.98e-06	0.000104	CcSEcCtD
Ciclesonide—Dermatitis—Epirubicin—hematologic cancer	7.98e-06	0.000104	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	7.96e-06	0.000324	CbGpPWpGaD
Ciclesonide—Headache—Epirubicin—hematologic cancer	7.93e-06	0.000104	CcSEcCtD
Ciclesonide—Dizziness—Doxorubicin—hematologic cancer	7.75e-06	0.000101	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—RPS14—hematologic cancer	7.56e-06	0.000308	CbGpPWpGaD
Ciclesonide—Nausea—Epirubicin—hematologic cancer	7.52e-06	9.82e-05	CcSEcCtD
Ciclesonide—CYP2D6—Metabolism—SMPD3—hematologic cancer	7.47e-06	0.000304	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NUP98—hematologic cancer	7.44e-06	0.000303	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—hematologic cancer	7.44e-06	0.000303	CbGpPWpGaD
Ciclesonide—Rash—Doxorubicin—hematologic cancer	7.39e-06	9.64e-05	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—hematologic cancer	7.38e-06	9.63e-05	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—hematologic cancer	7.34e-06	9.58e-05	CcSEcCtD
Ciclesonide—NR3C1—Gene Expression—NUP214—hematologic cancer	7.17e-06	0.000292	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	6.97e-06	0.000284	CbGpPWpGaD
Ciclesonide—Nausea—Doxorubicin—hematologic cancer	6.96e-06	9.08e-05	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	6.94e-06	0.000283	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	6.87e-06	0.00028	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	6.71e-06	0.000273	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	6.6e-06	0.000269	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPB1—hematologic cancer	6.6e-06	0.000269	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ASNS—hematologic cancer	6.53e-06	0.000266	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—B3GAT1—hematologic cancer	6.53e-06	0.000266	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DCK—hematologic cancer	6.53e-06	0.000266	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	6.43e-06	0.000262	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	6.4e-06	0.000261	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SMC1A—hematologic cancer	6.32e-06	0.000258	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	6.32e-06	0.000257	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—H3F3A—hematologic cancer	6.2e-06	0.000253	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HDC—hematologic cancer	6.19e-06	0.000252	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	6.09e-06	0.000248	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EZH2—hematologic cancer	5.95e-06	0.000242	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PARP1—hematologic cancer	5.82e-06	0.000237	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CDA—hematologic cancer	5.66e-06	0.000231	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HDAC2—hematologic cancer	5.62e-06	0.000229	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PC—hematologic cancer	5.45e-06	0.000222	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GMPS—hematologic cancer	5.34e-06	0.000218	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PHYH—hematologic cancer	5.34e-06	0.000218	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FTCD—hematologic cancer	5.34e-06	0.000218	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GBA—hematologic cancer	5.26e-06	0.000214	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC35B2—hematologic cancer	5.26e-06	0.000214	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SMPD3—hematologic cancer	4.88e-06	0.000199	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AR—hematologic cancer	4.87e-06	0.000198	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTAP—hematologic cancer	4.81e-06	0.000196	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CDKN2B—hematologic cancer	4.49e-06	0.000183	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FHL2—hematologic cancer	4.29e-06	0.000175	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	4.27e-06	0.000174	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DCK—hematologic cancer	4.27e-06	0.000174	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ASNS—hematologic cancer	4.27e-06	0.000174	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOR1—hematologic cancer	4.26e-06	0.000173	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AGRN—hematologic cancer	4.21e-06	0.000171	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HDC—hematologic cancer	4.05e-06	0.000165	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—IDH2—hematologic cancer	3.99e-06	0.000163	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMMR—hematologic cancer	3.99e-06	0.000163	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ARNTL—hematologic cancer	3.75e-06	0.000153	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CDA—hematologic cancer	3.7e-06	0.000151	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA9—hematologic cancer	3.65e-06	0.000149	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACP5—hematologic cancer	3.65e-06	0.000149	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	3.61e-06	0.000147	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOR2—hematologic cancer	3.6e-06	0.000147	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PC—hematologic cancer	3.56e-06	0.000145	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GBA—hematologic cancer	3.44e-06	0.00014	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	3.44e-06	0.00014	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—IDH1—hematologic cancer	3.43e-06	0.00014	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK14—hematologic cancer	3.41e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCC3—hematologic cancer	3.39e-06	0.000138	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TXN—hematologic cancer	3.39e-06	0.000138	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTO1—hematologic cancer	3.39e-06	0.000138	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR1—hematologic cancer	3.34e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SPHK1—hematologic cancer	3.32e-06	0.000135	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH1—hematologic cancer	3.23e-06	0.000132	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UGT1A1—hematologic cancer	3.19e-06	0.00013	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTAP—hematologic cancer	3.15e-06	0.000128	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC22A1—hematologic cancer	3.1e-06	0.000126	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CRABP1—hematologic cancer	3.1e-06	0.000126	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.02e-06	0.000123	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.93e-06	0.000119	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NUP98—hematologic cancer	2.93e-06	0.000119	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADCY7—hematologic cancer	2.84e-06	0.000116	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA3—hematologic cancer	2.84e-06	0.000116	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NUP214—hematologic cancer	2.82e-06	0.000115	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FHL2—hematologic cancer	2.81e-06	0.000114	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTR—hematologic cancer	2.77e-06	0.000113	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG2—hematologic cancer	2.77e-06	0.000113	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AGRN—hematologic cancer	2.75e-06	0.000112	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENO2—hematologic cancer	2.71e-06	0.00011	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—hematologic cancer	2.63e-06	0.000107	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMMR—hematologic cancer	2.61e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—IDH2—hematologic cancer	2.61e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SDC1—hematologic cancer	2.57e-06	0.000105	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.45e-06	9.99e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA9—hematologic cancer	2.39e-06	9.72e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACP5—hematologic cancer	2.39e-06	9.72e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.35e-06	9.59e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—IDH1—hematologic cancer	2.24e-06	9.14e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.22e-06	9.03e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TXN—hematologic cancer	2.22e-06	9.03e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.22e-06	9.03e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CD44—hematologic cancer	2.19e-06	8.9e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NQO1—hematologic cancer	2.19e-06	8.9e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.17e-06	8.84e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.09e-06	8.49e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYCS—hematologic cancer	2.07e-06	8.43e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.06e-06	8.37e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.03e-06	8.26e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.03e-06	8.26e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.98e-06	8.05e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NUP98—hematologic cancer	1.91e-06	7.8e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.86e-06	7.57e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.86e-06	7.57e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NUP214—hematologic cancer	1.85e-06	7.52e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.82e-06	7.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.81e-06	7.36e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTR—hematologic cancer	1.81e-06	7.36e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.79e-06	7.28e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENO2—hematologic cancer	1.77e-06	7.22e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—hematologic cancer	1.74e-06	7.08e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.73e-06	7.03e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.72e-06	7.01e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SDC1—hematologic cancer	1.68e-06	6.85e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.68e-06	6.82e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.68e-06	6.82e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.48e-06	6.03e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CD44—hematologic cancer	1.43e-06	5.82e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NQO1—hematologic cancer	1.43e-06	5.82e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYCS—hematologic cancer	1.35e-06	5.51e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.34e-06	5.47e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.24e-06	5.07e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—hematologic cancer	1.21e-06	4.91e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.19e-06	4.86e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.15e-06	4.7e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.13e-06	4.6e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.1e-06	4.46e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.1e-06	4.46e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.09e-06	4.46e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—hematologic cancer	1.08e-06	4.4e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.03e-06	4.21e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—hematologic cancer	9.68e-07	3.94e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CB—hematologic cancer	9.53e-07	3.88e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—hematologic cancer	8.24e-07	3.36e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	8.13e-07	3.31e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—EP300—hematologic cancer	7.85e-07	3.2e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CREBBP—hematologic cancer	7.54e-07	3.07e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	7.15e-07	2.91e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—hematologic cancer	7.06e-07	2.88e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	6.75e-07	2.75e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	6.23e-07	2.54e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—hematologic cancer	5.81e-07	2.37e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—hematologic cancer	5.39e-07	2.19e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—EP300—hematologic cancer	5.14e-07	2.09e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—hematologic cancer	4.75e-07	1.93e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.8e-07	1.55e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—hematologic cancer	3.1e-07	1.26e-05	CbGpPWpGaD
